Navigation Links
NewYork-Presbyterian/Weill Cornell creates world-class cancer center
Date:2/5/2008

NEW YORK (Feb. 5, 2008) -- NewYork-Presbyterian Hospital/Weill Cornell Medical Center has created an expanded cancer program dedicated to advancing research, prevention and treatment of the disease. The new Cancer Center is led by renowned cancer physician-scientist Dr. Andrew Dannenberg.

A joint initiative of Weill Cornell Medical College and NewYork-Presbyterian Hospital, the Center will create strengthened and expanded research programs and multidisciplinary collaborations.

"This bold initiative will build on our strengths to create a cancer center dedicated to improving the diagnosis and treatment of patients," says Dr. Antonio M. Gotto, Jr., the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College. "By our commitment to advancing cancer research from bench to bedside, we will fulfill our mission of unlocking scientific and medical discoveries to improve lives around the globe."

"Our goal is to transform what is already an excellent cancer program into a renowned cancer center, investing in areas where we have historic strength -- such as lymphoma, lung cancer, genitourinary and preventive oncology -- while establishing new programs that can be uniquely identified with NewYork-Presbyterian/Weill Cornell," says Dr. Herbert Pardes, president and CEO of NewYork-Presbyterian Hospital.

"Cancer is the second leading cause of death in the U.S. While scientific progress continues, close to 1.5 million people will be diagnosed this year. Many of these cases will be found after the cancer has spread to other parts of the body. New ideas are desperately needed to understand why cancers form, grow and spread and how to contain them, predict them and ultimately prevent them," says Dr. David P. Hajjar, senior executive vice dean and executive vice provost of Weill Cornell Medical College and dean of Weill Cornell's Graduate School of Medical Sciences.

In conjunction with this new Center, we have committed 10 new positions for the recruitment of cancer biologists, adds Dr. Hajjar.

"The key to the success of this initiative will be collaboration and team science. Our program will facilitate interactions between physicians and scientists from a wide variety of fields -- everything from hematology and oncology to radiology, surgery, urology, genetics, pediatrics, immunology, pharmacology, even communication sciences -- helping them to create synergies that might not otherwise exist," says Dr. Dannenberg, the Henry R. Erle, M.D.Roberts Family Professor of Medicine at Weill Cornell Medical College and a leading gastroenterologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

"These multidisciplinary collaborations will extend to our colleagues at Cornell University-Ithaca, Weill Cornell Medical CollegeQatar and the Methodist Hospital in Houston, Texas," he notes.

A leading authority in cancer prevention, Dr. Dannenberg has pioneered research helping to understand the link between inflammation and cancer -- and to elucidate the mechanisms by which nonsteroidal anti-inflammatory drugs such as aspirin reduce the risk of developing certain cancers. Dr. Dannenberg has held a series of leadership positions in the American Association for Cancer Research (AACR), and serves on the editorial boards of several leading basic science and clinical oncology journals.

"We also aim to improve our physical infrastructure, with additional lab space and shared resources to stimulate the advances that are so badly needed," adds Dr. Dannenberg.


'/>"/>
Contact: Lezlie Greenberg
leg2003@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Related medicine news :

1. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
2. Weill Cornell receives $2.4 million in grants from Gates Foundation to fight tuberculosis
3. White House awards Weill Cornells Bruce McCandliss highest honor for early career scientists
4. Healthy restaurants help make us fat, says a new Cornell study
5. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
6. Bobbi Brown Cosmetics Creates Limited-Edition Lip Palette in Partnership with The Heart Truths Red Dress Collection 2008 Fashion Show
7. Bobbi Brown Cosmetics Creates Limited-Edition Red Lip Palette in Partnership With The Heart Truths 2008 Red Dress Collection
8. Gene That Creates Cerebral Cortex Discovered
9. National Heart Lung and Blood Institute creates national network to study cardiovascular disease
10. inVentiv Health Creates Client Development and Integration Team
11. Creative Technology Services Creates a New Operating Company Focused on Mobility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... could substantially improve drug safety and minimize the cost of development. In this ... channel inhibition using cell lines and for cardiac toxicity using induced pluripotent stem ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... name the Creator responds to and which He does not. Yisrayl says with so ... one is the true name, but he says with a little Scripture, backed with a ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... their work assisting the Brooke Grove Foundation implement a Microsoft Dynamics GP solution ... Solutions, a leading ERP expert that specializes in long-term care, Brooke Grove now ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor that has ... presence to an educational purpose as the host of the “Informed” series. The program ... a recent episode, the series focuses on thyroid cancer. , Although thyroid cancer is ...
(Date:4/27/2017)... and DENVER (PRWEB) , ... April 27, 2017 ... ... Health, the nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement ... is enabled by the continuing support of the Jane and Leonard Korman Family ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ... & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... , Chief Executive Officer of the Company is scheduled to present ... Richard Bear and the Chairman of the Board, Tony ... ...
Breaking Medicine Technology: